Download PDF
Go back to website
If you have problems to see the content please click here
Other users also viewed these articles
Recommendations of the Spanish Society of Neonatology for the prevention of severe respiratory syncytial virus infections with nirsevimab, for the 2024–2025 season
Manuel Sánchez Luna, M. Luz Couce Pico, Belén Fernández Colomer
10.1016/j.anpede.2024.09.010
Recommendations of the Spanish Society of Pediatric Cardiology and Congenital Heart Diseases for the prevention of respiratory syncytial virus infections with nirsevimab in pediatric cardiology
Constancio Medrano López, Fernando Centeno Malfaz, María Garcés Sánchez
10.1016/j.anpede.2023.10.011
An update of the recommendations of the spanish neonatology society for the use of paivizumab as prophylaxis for severe infections due to syncytial respiratory virus in high risk infants
Manuel Sánchez Luna, Alejandro Pérez Muñuzuri, José Luis Leante Castellanos, César W. Ruiz Campillo, Ester Sanz López, Isabel Benavente Fernández, María Dolores Sánchez Redondo, Segundo Rite Gracia
10.1016/j.anpede.2019.08.003